Preparing for highly active antiretroviral therapy rollout in rural South Africa: An assessment using the information, motivation, and behavioral skills model

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 22, Issue 4, 2010, Pages 462-474

  Simon, Margo D ^a,b   Altice, Frederick L ^a   Moll, Anthony P ^c,d   Shange, Mbuso ^d   Friedland, Gerald H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Church of Scotland Hospital   (South Africa)

^d Philanjalo ^*  (South Africa)

Author keywords

Antiretroviral therapy; Attitudes; Health knowledge; HIV; Medication adherence; Practice; South Africa

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONDOM; CROSS-SECTIONAL STUDY; FEMALE; HEALTH BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF CONCEPT; SOUTH AFRICA; STIGMA; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CONDOMS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MODELS, PSYCHOLOGICAL; MOTIVATION; PATIENT ACCEPTANCE OF HEALTH CARE; RISK-TAKING; SAFE SEX; SOUTH AFRICA; YOUNG ADULT;

EID: 77951681585     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120903220253     Document Type: Article

References (72)

1. Abdool Karim, Q. (2004). HIV treatment in South Africa: Overcoming impediments to get started. Lancet, 363(9418), 1394.
2. Altice, F.L., & Friedland, G.H. (1998). The era of adherence to HIV therapy. Annals of Internal Medicine, 129(6), 503-505.
3. Altice, F.L., Mostashari, F., & Friedland, G.H. (2001). Trust and the acceptance of and adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 28(1), 47-58.
4. Amico, K.R., Toro-Alfonso, J., & Fisher, J.D. (2005). An empirical test of the information, motivation and behavioral skills model of antiretroviral therapy adherence. AIDS Care, 17(6), 661-673.
5. Ammassari, A., Trotta, M.P., Murri, R., Castelli, F., Narciso, P., Noto, P., et al. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndrome, 31(Suppl. 3), S123-S127.
6. Bandura, A. (1989). Perceived self-efficacy in the exercise of control over AIDS Infection. In V.M. Mays, G.W. Albee, & S.F. Schneider (Eds.), Primary prevention of AIDS (pp. 128-141). Newbury Park, CA: Sage.
7. Bangsberg, D.R., Moss, A.R., & Deeks, S.G. (2004). Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. Journal of Antimicrobial Chemotherapy, 53(5), 696-699.
8. Beaton, D.E., Bombardier, C., Guillemin, F., & Ferraz, M.B. (2000). Guidelines for the process of cross-cultural adaptation of self-report measures. Spine, 25(24), 3186-3191.
9. Belzer, M.E., Fuchs, D.N., Luftman, G.S., & Tucker, D.J. (1999). Antiretroviral adherence issues among HIV-positive adolescents and young adults. Journal of Adolescent Health, 25(5), 316-319.
10. Bertholon, D.R., Rossert, H., & Korsia, S. (1999). The patient's perspective on life with antiretroviral treatment: Results of an 887-person survey. AIDS Reader, 9(7), 462-469.
11. Blower, S., Bodine, E., Kahn, J., & McFarland, W. (2005). The antiretroviral rollout and drug-resistant HIV in Africa: Insights from empirical data and theoretical models. AIDS, 19(1), 1-14.
12. Brown, S., Brown, N., Lurie, M., Richards, D., Mokoua, L., Carrara, H., et al. (2006, August 13-18). Assessment of antiretroviral treatment readiness and predictors of adherence to highly active antiretroviral therapy among callers to the South African national AIDS helpline [Abstract]. Poster session presented at AIDS 2006-XVI International AIDS Conference in Toronto, Canada, Abstract No. TUPE0753.
13. Chopra, M., Kendall, C., Hill, Z., Schaay, N., Nkonki, L.L., & Doherty, T.M. (2006). "Nothing new": Responses to the introduction of antiretroviral drugs in South Africa. AIDS, 20(15), 1975-1977.
14. Day, J.H., Miyamura, K., Grant, A.D., Leeuw, A., Munsamy, J., Baggaley, R., et al. (2003). Attitudes to HIV voluntary counselling and testing among mine-workers in South Africa: Will availability of antiretroviral therapy encourage testing? AIDS Care, 15(5), 665-672.
15. de la Rosa, R., Ruiz-Mateos, E., Rubio, A., Abad, M.A., Vallejo, A., Rivero, L., et al. (2004). Long-term virological outcome and resistance mutations at vir-ological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapy. Journal of Antimicrobial Chemotherapy, 53(1), 95-101.
16. Degefa, A., Sanders, E.J., Mekonnen, Y., Messele, T., Wolday, D., Dorigo-Zetsma, W., et al. (2003). Knowledge and attitudes towards antiretroviral therapy among factory workers participating in a cohort on HIV and AIDS, Addis Ababa, Ethiopia. Ethiopian Medical Journal, 41(Suppl. 1), 75-87.
17. Department: Provincial and Local Government. (n.d.). Umzinyathi-overview of the node. Retrieved December 2004, from http://www.dplg.gov.za/html/progs/ isrdp-Nodes/Umzinyathi.htm
18. Etiebet, M.A., Fransman, D., Forsyth, B., Coetzee, N., & Hussey, G. (2004). Integrating prevention of mother-to-child HIV transmission into antenatal care: Learning from the experiences of women in South Africa. AIDS Care, 16(1), 37-46.
19. Fishbein, M., & Ajzen, I. (1975). Belief, attitude, intention, and behavior: An introduction to theory and research. Reading, MA: Addison-Wesley.
20. Fisher, J.D., Cornman, D.H., Osborn, C.Y., Amico, K.R., Fisher, W.A., & Friedland, G.A. (2004). Clinician-initiated HIV risk reduction intervention for HIV-positive persons: Formative research, acceptability, and fidelity of the options project. Journal of Acquired Immune Deficiency Syndrome, 37(Suppl. 2), S78-S87.
21. Fisher, J.D., & Fisher, W.A. (1992). Changing AIDS-risk behavior. Psychological Bulletin, 111(3), 455-474.
22. Fisher, J.D., Fisher, W.A., Amico, K.R., & Harman, J.J. (2006). An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychology, 25(4), 462-473.
23. Fisher, J.D., Fisher, W.A., Misovich, S.J., Kimble, D.L., & Malloy, T.E. (1996). Changing AIDS risk behavior: Effects of an intervention emphasizing AIDS risk reduction information, motivation, and behavioral skills in a college student population. Health Psychology, 15(2), 114-123.
24. Friedland, G. (2002, March). Adherence to highly active antiretroviral therapy. Southern African Journal of HIV Medicine, 3(1), 35-41.
25. Friedland, G.H., & Williams, A. (1999). Attaining higher goals in HIV treatment: The central importance of adherence. AIDS, 13(Suppl. 1), S61-S72.
26. Gandhi, N.R., Moll, A.P., Lalloo, U., Pawinski, R., Zeller, K., Moodley, P., et al. (2009). Successful integration of tuberculosis and HIV treatment in rural South Africa: The Sizonq'oba study. Journal of Acquired Immune Deficiency Syndrome, 50(1), 37-43.
27. Gao, X., Nau, D.P., Rosenbluth, S.A., Scott, V., & Woodward, C. (2000). The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care, 12(4), 387-398. (Pubitemid 30618183)
28. Garcia, R., Schooley, R.T., & Badaro, R. (2003). An adherence trilogy is essential for long-term HAART success. Brazilian Journal of Infectious Disease, 7(5), 307-314.
29. Gebrekristos, H.T., Lurie, M.N., Mthethwa, N., & Karim, Q.A. (2005a). Knowledge and acceptability of HAART among TB patients in Durban, South Africa. AIDS Care, 17(6), 767-772. (Pubitemid 41113014)
30. Gebrekristos, H.T., Mlisana, K.P., & Karim, Q.A. (2005b). Patients' readiness to start highly active antiretroviral treatment for HIV. BMJ, 331(7519), 772-775. (Pubitemid 41414950)
31. Harries, A.D., Nyangulu, D.S., Hargreaves, N.J., Kaluwa, O., & Salaniponi, F.M. (2001). Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet, 358(9279), 410-414. (Pubitemid 32739108)
32. Holzemer, W.L., Corless, I.B., Nokes, K.M., Turner, J.G., Brown, M.A., Powell-Cope, G.M., et al. (1999). Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDS, 13(3), 185-197. (Pubitemid 29155987)
33. Johnson, A., Lurie, M., Kubeka, M., Kunene, P., & Harrison, A. (2006, August 13-18). Attitudes toward ART and other AIDS treatment options among South African youth [Abstract]. Poster session presented at AIDS 2006-XVI International AIDS Conference in Toronto, Canada, Abstract No. CDD1095.
34. Johnson, M.O., Catz, S.L., Remien, R.H., Rotheram-Borus, M.J., Morin, S.F., Charlebois, E., et al. (2003). Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: Findings from the healthy living project. AIDS Patient Care STDS, 17(12), 645-656. (Pubitemid 38031552)
35. Kalichman, S.C., Rompa, D., DiFonzo, K., Simpson, D., Austin, J., Luke, W., et al. (2001). HIV treatment adherence in women living with HIV/AIDS: Research based on the information-motivation-behavioral skills model of health behavior. Journal of the Association of Nurses AIDS Care, 12(4), 58-67.
36. Kelly, J.A., Otto-Salaj, L.L., Sikkema, K.J., Pinkerton, S.D., & Bloom, F.R. (1998). Implications of HIV treatment advances for behavioral research on AIDS: Protease inhibitors and new challenges in HIV secondary prevention. Health Psychology, 17(4), 310-319. (Pubitemid 28345938)
37. Kozal, M.J., Amico, K.R., Chiarella, J., Schreibman, T., Cornman, D., Fisher, W., et al. (2004). Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care. AIDS, 18(16), 2185-2189. (Pubitemid 39463684)
38. KwaZulu-Natal Department of Health. (2002). KwaZulu-Natal epidemiology bulletin: HIV infection in KwaZulu-Natal: A provincial update-issue 1, November 2002. The epidemiology unit. Retrieved December 2004, from http://www.kznhealth. gov.za/epibulletin1.pdf
39. KwaZulu-Natal Department of Health. (2003a). KwaZulu-Natal epidemiology bulletin: Epidemiological estimates of infectious diseases in KwaZulu-Natal-issue 2, March 2003. The epidemiology unit. Retrieved December 2004, from http://www.kznhealth.gov.za/epibulletin2.pdf
40. KwaZulu-Natal Department of Health. (2003b). KwaZulu-Natal epidemiology bulletin: Epidemiology of chronic degenerative diseases in KwaZulu-Natal-issue 4, September 2003. The epidemiology unit. Retrieved December 2004, from http://www.kznhealth.gov.za/epibulletin4.pdf
41. Lee, K., Solts, B., & Burns, J. (2002). Investigating the psychosocial impact of anti-HIV combination therapies. AIDS Care, 14(6), 851-857. (Pubitemid 35454438)
42. Low-Beer, S., Yip, B., O'Shaughnessy, M.V., Hogg, R.S., & Montaner, J.S. (2000). Adherence to triple therapy and viral load response. Journal of Acquired Immune Deficiency Syndrome, 23(4), 360-361. (Pubitemid 30327043)
43. Lurie, M., Harrison, A., Kunene, P., Kubeka, M., & Williams, N. (2006, August 13-18). Knowledge and attitudes towards ART and related preventative behaviors among rural South African youth [Abstract]. Poster session presented at AIDS 2006-XVI International AIDS Conference in Toronto, Canada, Abstract No. WEPE0070.
44. Miller, L.G., Liu, H., Hays, R.D., Golin, C.E., Ye, Z., Beck, C.K., et al. (2003). Knowledge of antiretroviral regimen dosing and adherence: A longitudinal study. Clinical Infectious Disease, 36(4), 514-518.
45. Mills, E.J., Nachega, J.B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., et al. (2006). Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA, 296(6), 679-690.
46. Mshana, G.H., Wamoyi, J., Busza, J., Zaba, B., Changa-lucha, J., Kaluvya, S., et al. (2006). Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: A qualitative study of early rural referrals to the national program. AIDS Patient Care STDS, 20(9), 649-657.
47. Nachega, J.B., Knowlton, A.R., Deluca, A., Schoeman, J.H., Watkinson, L., Efron, A., et al. (2006). Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. Journal of Acquired Immune Deficiency Syndrome, 43(Suppl. 1), S127-S133.
48. Nachega, J.B., Lehman, D.A., Hlatshwayo, D., Motho-peng, R., Chaisson, R.E., & Karstaedt, A.S. (2005). HIV/AIDS and antiretroviral treatment knowledge, attitudes, beliefs, and practices in HIV-infected adults in Soweto, South Africa. Journal of Acquired Immune Deficiency Syndrome, 38(2), 196-201.
49. Nachega, J.B., & Mills, E.J. (2007). Antiretroviral therapy adherence in resource-limited and resource-rich settings: Current status of knowledge and research priorities. Therapy, 4(6), 775-786.
50. Nachega, J.B., Stein, D.M., Lehman, D.A., Hlatshwayo, D., Mothopeng, R., Chaisson, R.E., et al. (2004). Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Research and Human Retroviruses, 20(10), 1053-1056.
51. Orrell, C, Bangsberg, D.R., Badri, M., & Wood, R. (2003). Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS, 17(9), 1369-1375.
52. Pach 3rd., A., Cerbone, F.G., & Gerstein, D.R. (2003). A qualitative investigation of antiretroviral therapy among injection drug users. AIDS and Behavior, 7(1), 87-100.
53. Page-Shipp, L.S., Charalambous, S., Roux, S., Dias, B., Sefuti, C, Churchyard, G.J., et al. (2007). Attitudes to directly observed antiretroviral treatment in a workplace HIV care programme in South Africa. Sexually Transmitted Infections, 83(5), 383-386.
54. Paterson, D.L., Swindells, S., Mohr, J., Brester, M., Vergis, E.N., Squier, C, et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21-30.
55. Remien, R.H., Hirky, A.E., Johnson, M.O., Weinhardt, L.S., Whittier, D., & Le, G.M. (2003). Adherence to medication treatment: A qualitative study of facilitators and barriers among a diverse sample of HIV + men and women in four US cities. AIDS Behavior, 7(1), 61-72.
56. Sethi, A.K., Celentano, D.D., Gange, S.J., Moore, R.D., & Gallant, J.E. (2003). Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clinical Infectious Disease, 37(8), 1112-1118.
57. South Africa Department of Health (2003). National HIV and syphilis antenatal sero-prevalence survey in South Africa 2003. Retrieved December 2004, from http://www.doh.gov.za/docs/reports/2003/hiv/p1-23.pdf
58. South Africa Department of Health (2006). Broad framework for HIV & AIDS and STI strategic plan for South Africa, 2007-2011. Retrieved March 2008, from http://www.info.gov.za/issues/hiv/framework.pdf
59. South Africa Department of Health (2007). National HIV and syphilis prevalence survey, South Africa 2006-summary report. Retrieved March 22, 2008, from www.hivan.org.za/admin/documents/anchivsummary.pdf
60. Starace, F., Massa, A., Amico, K.R., & Fisher, J.D. (2006). Adherence to antiretroviral therapy: An empirical test of the information-motivation- behavioral skills model. Health Psychology, 25(2), 153-162.
61. Stenson, A.L., Charalambous, S., Dwadwa, T., Pemba, L., Du Toit, J.D., Baggaley, R., et al. (2005). Evaluation of antiretroviral therapy (ART)-related counselling in a workplace-based ART implementation programme, South Africa. AIDS Care, 17(8), 949-957.
62. Stone, V.E. (2001). Strategies for optimizing adherence to highly active antiretroviral therapy: Lessons from research and clinical practice. Clinical Infectious Disease, 33(6), 865-872.
63. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group (2000). Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: A randomised trial. Lancet, 356(9224), 103-112.
64. Tuldra, A., & Wu, A.W. (2002). Interventions to improve adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 31(Suppl. 3), S154-S157.
65. UNAIDS (2007). AIDS epidemic update. Retrieved March 2008, from http://data.unaids.org/pub/EPISlides/2007/2007-epiupdate-en.pdf
66. Wainberg, M.A., & Friedland, G. (1998). Public health implications of antiretroviral therapy and HIV drug resistance. JAMA, 279(24), 1977-1983.
67. Walker, L., Reid, G., & Cornell, M. (2003). Waiting to happen: HIV/AIDS in South Africa: The bigger picture. Cape Town, South Africa: Double Storey Books.
68. Weinhardt, L.S., Carey, M.P., Johnson, B.T., & Bickham, N.L. (1999). Effects of HIV counseling and testing on sexual risk behavior: A meta-analytic review of published research, 1985-1997. American Journal of Public Health, 89(9), 1397-1405.
69. Weiss, J.J. (2000). Attitudinal factors and adherence to protease inhibitor combination therapy. In J.P. Moatti, Y. Soutegrand, A. Prieur, T. Sandfort, & P. Aggleton (Eds.), AIDS in Europe: New challenges for the social sciences (pp. 45-56). New York: Routledge.
70. WHO (2004). Coverage of selected services for HIV/AIDS prevention, care and support in low and middle income countries in 2003. Retrieved January 2005, from http://www.who.int/hiv/pub/prev-care/coverage/en/
71. Williams, N., Lurie, M., Kunene, P., Kubeka, M., Johnson, A., & Harrison, A. (2006, August 13-18). Reasons for low uptake of testing among young rural South Africans [Abstract]. Poster session presented at AIDS 2006-XVI International AIDS Conference in Toronto, Canada, Abstract No. TUPE0501.
72. Wood, E., Hogg, R.S., Yip, B., Harrigan, P.R., O'Shaugh-nessy, M.V., & Montaner, J.S. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Annals of Internal Medicine, 139(10), 810-816.